AptarGroup price target raised to $157 from $152 at Wells Fargo

Wells Fargo raised the firm’s price target on AptarGroup to $157 from $152 and keeps an Overweight rating on the shares. The firm remains constructive on AptarGroup’s Pharma outlook, given its robust pipeline and new capacity rollout in 2024. Further, given improved execution in Beauty and incremental cost out efforts in Closures, Wells recommends owning AptarGroup.